Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of VC005 gel in adolescents and adults with mild to moderate atopic dermatitis
CTR20261540Phase 3Active
- Sponsor
- Wecare Probiotics
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of VC-005 in atopic dermatitis (AD), sponsored by Wecare Probiotics. Started May 2026; status: active.
02
Drugs
VC-005
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20261540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261540.